Palmitic Acid

Palmitic Acid

SCHEMBL18247787

CCCCCCCCCCCCCCCC(=O)O.O=C1CCCCCO1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 7/20 0.52
▸ PPARG P37231 7/20 0.52
▸ PPARD Q03181 7/20 0.52
▸ PPARA Q07869 7/20 0.52
▸ HDAC11 Q96DB2 5/20 0.52
▸ TSHR P16473 4/20 0.52
▸ PTPN1 P18031 3/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ TLR2 O60603 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ FABP4 P15090 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ ALOX15 P16050 2/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ SLC22A6 Q4U2R8 1/20 0.52
▸ SLC22A8 Q8TCC7 1/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ ESR1 P03372 1/20 0.52
▸ PDE4A P27815 1/20 0.52
▸ PDE3A Q14432 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Octanoic Acid SCHEMBL28375032 1.00 GPR84 (0.52) GPR84PPARGPPARDPPARAHDAC11
Hexanoate SCHEMBL28426223 0.98 AKR1B1 (0.50) GPR84PPARGPPARDPPARAHDAC11
Valeric Acid SCHEMBL27694073 0.94 CA1 (0.52) GPR84PPARGPPARDPPARAHDAC11
Sebacic Acid SCHEMBL27861507 0.91 CA1 (0.59) GPR84PPARGPPARDPPARAHDAC11
Adipic Acid SCHEMBL7695374 0.91 CA1 (0.59) GPR84TSHRALDH1A1SLC22A6FFAR1
Azelaic Acid SCHEMBL6425047 0.91 CA1 (0.59) GPR84PPARGPPARDPPARAHDAC11
Azelaic Acid SCHEMBL1241300 0.88 CA1 (0.52) GPR84PPARGPPARDPPARAHDAC11
Azelaic Acid SCHEMBL1241958 0.88 CA1 (0.52) GPR84PPARGPPARDPPARAHDAC11
Ethylene Glycol SCHEMBL1239181 0.88 CA1 (0.52) GPR84PPARGPPARDPPARAHDAC11
SCHEMBL30017070 0.87 CA1 (0.48) GPR84PPARGPPARDPPARAHDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110740725-B Composition containing benzoic acid amide compound and cyclodextrin solubilizer 株式会社爱茉莉太平洋 2024-01-12 — — CN claimed
US-11673071-B2 Isotopic compositions BOTANICAL WATER TECHNOLOGIES IP LTD (GB) 2023-06-13 — — US claimed
US-11654094-B2 Composition comprising benzoic acid amide compound and cyclodextrin solubilizing agent AMOREPACIFIC CORPORATION (KR) 2023-05-23 — — US claimed
WO-2018182257-A1 COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT (주)아모레퍼시픽 2018-10-04 — — WO claimed
EP-3515571-B1 ISOTOPIC COMPOSITIONS BOTANICAL WATER TECH IP LTD (GB) 2026-01-07 — — EP disclosed
US-12151207-B2 Isotopic compositions II BOTANICAL WATER TECHNOLOGIES IP LTD (GB) 2024-11-26 — — US disclosed
EP-4464307-A1 COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME MPLUS COSMETICS S.R.L. (IT) 2024-11-20 — — EP disclosed
US-20240374498-A1 COSMETIC COMPOSITION AND METHODS OF MAKING THE SAME MPLUS COSMETICS S.R.L. (IT) 2024-11-14 — — US disclosed
CN-110740725-B Composition containing benzoic acid amide compound and cyclodextrin solubilizer 株式会社爱茉莉太平洋 2024-01-12 — — CN disclosed
US-11673071-B2 Isotopic compositions BOTANICAL WATER TECHNOLOGIES IP LTD (GB) 2023-06-13 — — US disclosed
US-11654094-B2 Composition comprising benzoic acid amide compound and cyclodextrin solubilizing agent AMOREPACIFIC CORPORATION (KR) 2023-05-23 — — US disclosed
US-20200368686-A1 ISOTOPIC COMPOSITIONS II BOTANICAL WATER TECHNOLOGIES IP LTD (GB) 2020-11-26 — — US disclosed
EP-3735394-A1 ISOTOPIC COMPOSITIONS II Botanical Water Technologies IP Ltd (GB) 2020-11-11 — — EP disclosed
US-20200246376-A1 HYDROGEN BASED COMPOSITIONS HYDROGEN4HEALTH PTY LTD (AU) 2020-08-06 — — US disclosed
EP-3689356-A1 HYDROGEN-BASED COMPOSITIONS Hydrogen4Health Pty Ltd (AU) 2020-08-05 — — EP disclosed
WO-2018182257-A1 COMPOSITION COMPRISING BENZOIC ACID AMIDE COMPOUND AND CYCLODEXTRIN SOLUBILIZING AGENT (주)아모레퍼시픽 2018-10-04 — — WO disclosed
WO-2016183633-A1 SKIN CLEANSING COMPOSITION SNDR PTY LTD (AU) 2016-11-24 — — WO disclosed
WO-2016183630-A1 SKIN MOISTURIZING COMPOSITION SNDR PTY LTD (AU) 2016-11-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11654094-B2 Composition comprising benzoic acid amide compound and cyclodextrin solubilizing agent CEL, ABCG2, TBCA GPR84 812/4885PPARG 193/4885PPARD 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback